Danielski earns grant to attend ACNP
![Dr. Lucineia Danielski](https://med.uth.edu/wp-content/uploads/2024/08/Danielski_Lucineia.jpg)
Lucineia Danielski, PharmD, PhD, postdoctoral fellow in the Translational Psychiatry Program at the Louis A. Faillace, MD, Department of Psychiatry and Behavioral Sciences, received a grant from the International Brain Research Organization to attend the ACNP conference in December 2024 in Phoenix.
Every year, the organization gives grants to fund a broad range of opportunities to support neuroscience research and education around the world. By receiving the grant to attend the conference, Danielski can share her research and receive valuable feedback and network.
Her research focuses on discovering how infectious diseases such as sepsis and meningitis can generate or worsen neurodegeneration, as observed in patients with Alzheimer’s disease. Danielski studies sepsis-associated encephalopathy, including exploring the consequences of inflammation in the brain following infection.
Danielski will present a summary of her current work under the guidance of Tatiana Barichello, PhD, associate professor in the Faillace Department of Psychiatry and Behavioral Sciences, where the research group reports elevated Aβ levels, a marker of Alzheimer’s disease, in preclinical models with pneumococcal meningitis.
Danielski’s career is deeply rooted in translational research, necessitating integrating knowledge from various healthcare domains, including intensive care, neurology, inflammation, infection, psychiatry, and behavioral sciences.
Danielski is excited to have received the grant and attend the conference and feels like getting recognition for her work validates her career choice and underscores the importance of research efforts for patients who depend on medical advancements.
“The American College of Neuropsychopharmacology is a notable agency, and this will be my first time in the meeting,” Danielski said. “The annual meeting is one of the world’s leading forums for exchanging cutting-edge scientific information about the brain, behavior, and psychotropic drugs. So, in that case, my research matches perfectly with this meeting.”